168 related articles for article (PubMed ID: 34222045)
1. Isolation of Mutants With Reduced Susceptibility to Piperaquine From a Mutator of the Rodent Malaria Parasite
Ikeda M; Hirai M; Tachibana SI; Mori T; Mita T
Front Cell Infect Microbiol; 2021; 11():672691. PubMed ID: 34222045
[TBL] [Abstract][Full Text] [Related]
2. A Variant PfCRT Isoform Can Contribute to
Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
mBio; 2017 May; 8(3):. PubMed ID: 28487425
[TBL] [Abstract][Full Text] [Related]
3. A single point mutation in the Plasmodium falciparum 3'-5' exonuclease does not alter piperaquine susceptibility.
Boonyalai N; Kirativanich K; Thamnurak C; Praditpol C; Vesely BA; Wojnarski M; Griesenbeck JS; Waters NC
Malar J; 2022 Apr; 21(1):130. PubMed ID: 35459163
[TBL] [Abstract][Full Text] [Related]
4. Mutant PfCRT Can Mediate Piperaquine Resistance in African Plasmodium falciparum With Reduced Fitness and Increased Susceptibility to Other Antimalarials.
Wicht KJ; Small-Saunders JL; Hagenah LM; Mok S; Fidock DA
J Infect Dis; 2022 Nov; 226(11):2021-2029. PubMed ID: 36082431
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium berghei K13 Mutations Mediate
Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance.
Small-Saunders JL; Hagenah LM; Wicht KJ; Dhingra SK; Deni I; Kim J; Vendome J; Gil-Iturbe E; Roepe PD; Mehta M; Mancia F; Quick M; Eppstein MJ; Fidock DA
PLoS Pathog; 2022 Feb; 18(2):e1010278. PubMed ID: 35130315
[TBL] [Abstract][Full Text] [Related]
7. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
[TBL] [Abstract][Full Text] [Related]
8. Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.
Kiboi D; Irungu B; Orwa J; Kamau L; Ochola-Oyier LI; Ngángá J; Nzila A
Exp Parasitol; 2014 Dec; 147():23-32. PubMed ID: 25448357
[TBL] [Abstract][Full Text] [Related]
9. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
[TBL] [Abstract][Full Text] [Related]
10. Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine.
Ross LS; Dhingra SK; Mok S; Yeo T; Wicht KJ; Kümpornsin K; Takala-Harrison S; Witkowski B; Fairhurst RM; Ariey F; Menard D; Fidock DA
Nat Commun; 2018 Aug; 9(1):3314. PubMed ID: 30115924
[TBL] [Abstract][Full Text] [Related]
11. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
[TBL] [Abstract][Full Text] [Related]
12. Structure and drug resistance of the Plasmodium falciparum transporter PfCRT.
Kim J; Tan YZ; Wicht KJ; Erramilli SK; Dhingra SK; Okombo J; Vendome J; Hagenah LM; Giacometti SI; Warren AL; Nosol K; Roepe PD; Potter CS; Carragher B; Kossiakoff AA; Quick M; Fidock DA; Mancia F
Nature; 2019 Dec; 576(7786):315-320. PubMed ID: 31776516
[TBL] [Abstract][Full Text] [Related]
13. Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.
Ye R; Zhang Y; Zhang D
Parasit Vectors; 2022 Apr; 15(1):130. PubMed ID: 35413937
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
15. Generation of rodent malaria parasites with a high mutation rate by destructing proofreading activity of DNA polymerase δ.
Honma H; Hirai M; Nakamura S; Hakimi H; Kawazu S; Palacpac NM; Hisaeda H; Matsuoka H; Kawai S; Endo H; Yasunaga T; Ohashi J; Mita T; Horii T; Furusawa M; Tanabe K
DNA Res; 2014 Aug; 21(4):439-46. PubMed ID: 24670267
[TBL] [Abstract][Full Text] [Related]
16. A
Kane J; Li X; Kumar S; Button-Simons KA; Vendrely Brenneman KM; Dahlhoff H; Sievert MAC; Checkley LA; Shoue DA; Singh PP; Abatiyow BA; Haile MT; Nair S; Reyes A; Tripura R; Peto TJ; Lek D; Mukherjee A; Kappe SHI; Dhorda M; Nkhoma SC; Cheeseman IH; Vaughan AM; Anderson TJC; Ferdig MT
mBio; 2024 Jun; ():e0080524. PubMed ID: 38912775
[TBL] [Abstract][Full Text] [Related]
17. In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.
Hao M; Jia D; Li Q; He Y; Yuan L; Xu S; Chen K; Wu J; Shen L; Sun L; Zhao H; Yang Z; Cui L
Antimicrob Agents Chemother; 2013 Apr; 57(4):1723-9. PubMed ID: 23357760
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine.
Mukherjee A; Gagnon D; Wirth DF; Richard D
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates.
Foguim FT; Bogreau H; Gendrot M; Mosnier J; Fonta I; Benoit N; Amalvict R; Madamet M; Wein S; Pradines B;
Malar J; 2020 Jun; 19(1):201. PubMed ID: 32503540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
